Bempedoic acid and/or its fixed-dose combination with ezetimibe
Showing 1 - 25 of >10,000
Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe
Not yet recruiting
- Primary Hypercholesterolemia
- Mixed Dyslipidemia
- Bempedoic acid and/or its fixed dose combination with ezetimibe
- (no location specified)
Mar 23, 2023
Healthy Lactating Women Trial in Las Vegas (Bempedoic Acid 180 MG Oral Tablet, Bempedoic Acid/Ezetimibe 180 MG-10 MG Oral
Recruiting
- Healthy Lactating Women
- Bempedoic Acid 180 MG Oral Tablet
- Bempedoic Acid/Ezetimibe 180 MG-10 MG Oral Tablet
-
Las Vegas, NevadaPPD Development, Las Vegas Research Unit
Aug 27, 2023
Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe
Active, not recruiting
- Hypercholesterolemia
- Mixed Dyslipidemia
- Bempedoic acid and/or its fixed-dose combination with ezetimibe
-
Aue, Germany
- +126 more
May 9, 2022
Healthy Volunteer Study Trial (Fixed-Dose Combination (FDC) Tablet)
Not yet recruiting
- Healthy Volunteer Study
- Fixed-Dose Combination (FDC) Tablet
- (no location specified)
Sep 22, 2023
Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)
Not yet recruiting
- Dyslipidemias
- +4 more
- Combination Therapy
- +5 more
- (no location specified)
Aug 22, 2023
Bempedoic Acid Pregnancy Surveillance Program
Recruiting
- Pregnancy
- Hyperlipidemias
- Bempedoic Acid
- Bempedoic Acid / Ezetimibe
-
Morrisville, North CarolinaEvidera, PPD business unit
Oct 21, 2021
Efficacy of Fixed Dose Combination Therapy With Atorvastatin and
Enrolling by invitation
- Primary Hypercholesterolemia
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Nov 4, 2022
Describe Key Factors Leading to Physician's Decision to Treat
Completed
- Hypercholesterolemia
- Mixed Dyslipidemia
- Bempedoic Acid 180Mg/Ezetimibe 10Mg Tab
- No study drug
-
Arnsberg, Germany
- +62 more
Nov 30, 2022
Manganese Safety in Adults Trial (Tralement, Fixed-dose trace element combination product of zinc, copper, and selenious acid)
Not yet recruiting
- Manganese Safety in Adults
- Tralement
- Fixed-dose trace element combination product of zinc, copper, and selenious acid
- (no location specified)
Feb 1, 2023
Fixed-dose Combination Rosuvastatin/Ezetimibe for Dyslipidaemia
Completed
- Dyslipidemias
- Rosuvastatin 10 or 20mg /Ezetimibe 10 mg Fixed Dose
-
Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
Feb 28, 2022
Manganese Safety in Pediatric Patients Trial (Tralement, Fixed-dose trace element combination product of zinc, copper, and
Not yet recruiting
- Manganese Safety in Pediatric Patients
- Tralement
- Fixed-dose trace element combination product of zinc, copper, and selenious acid
- (no location specified)
Feb 1, 2023
Healthy Male Subjects Trial in Auckland, Christchurch (Fixed-Dose Combination of Pertuzumab and Trastuzumab SC (PH FDC SC),
Recruiting
- Healthy Male Subjects
- Fixed-Dose Combination of Pertuzumab and Trastuzumab SC (PH FDC SC)
- +2 more
-
Adelaide, South Australia, Australia
- +3 more
Feb 1, 2023
PD-L1-selected Solid Tumors Trial in Spokane (Tiragolumab and Atezolizumab IV FDC)
Recruiting
- PD-L1-selected Solid Tumors
- Tiragolumab and Atezolizumab IV FDC
-
Spokane, WashingtonMedical Oncology Associates
Jan 13, 2023
Healthy Trial in Mexico City (Rosuvastatin (20mg) /Ezetimibe (10mg) in fixed dose, Rosuvastatin 20mg, Ezetimibe 10mg)
Completed
- Healthy
- Rosuvastatin (20mg) /Ezetimibe (10mg) in fixed dose
- +2 more
-
Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
Aug 20, 2021
Cardiovascular Disorder, Diabetes Trial (ezetimibe (+) simvastatin, simvastatin 40 mg or atorvastatin 20 mg, Rosuvastatin)
Completed
- Cardiovascular Disorder
- Diabetes Mellitus
- ezetimibe (+) simvastatin
- +3 more
- (no location specified)
Feb 7, 2022
Hyperlipidemias Trial in United States (Bempedoic Acid + Ezetimibe Fixed-Dose Combination, Bempedoic Acid, Ezetimibe)
Completed
- Hyperlipidemias
- Bempedoic Acid + Ezetimibe Fixed-Dose Combination
- +3 more
-
Ames, Iowa
- +4 more
Mar 25, 2020
Healthy Volunteers Trial in Navi Mumbai (nefopam HCl 30mg X2, paracetamol 500 mg X2, Combination Product: nefopam HCl 30mg /
Completed
- Healthy Volunteers
- nefopam hydrochloride 30mg X2
- +2 more
-
Navi Mumbai, IndiaAccutest Research Laboratories
Mar 9, 2022
Preservative-free Fixed-dose Combination of Tafluprost 0.0015% /
Completed
- Ocular Surface Disease
- Primary Open Angle Glaucoma
- Tafluprost, timolol maleate
-
Taoyuan city, TaiwanChang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospita
Oct 27, 2022
Hypertension, Hypertension,Essential Trial (fixed-dose of olmesartan 20mg/40 mg + indapamide 1,5 mg, Isolated drugs Olmesartan
Not yet recruiting
- Hypertension
- Hypertension,Essential
- fixed-dose of olmesartan 20mg/40 mg + indapamide 1,5 mg
- Isolated drugs Olmesartan (20 mg or 40 mg) and Indapamide (1,5 mg)
- (no location specified)
Mar 17, 2022
Adult Solid Tumor Trial in Chicago (Carboplatin, Laboratory Biomarker Analysis, Paclitaxel)
Active, not recruiting
- Adult Solid Neoplasm
- Carboplatin
- +4 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jan 25, 2023
Patients Treated With Telmisartan/Hydrochlorothiazide or
Withdrawn
- Hypertension
- subjects treated with telmisartan/hydrochlorothiazide
- +3 more
-
Tokyo, JapanNippon Boehringer Ingelheim Co., Ltd.
Jun 23, 2022
Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)
Recruiting
- Solid Tumor
- Hematological Malignancy
-
East Melbourne, Victoria, Australia
- +4 more
Jan 11, 2023
Diabetes, Diabetes, Type 2, Cholesterolemia Trial in United States (Bempedoic acid + Ezetimibe FDC Oral Tablet, Ezetimibe 10 mg
Completed
- Diabetes
- +2 more
- Bempedoic acid + Ezetimibe FDC Oral Tablet
- +3 more
-
Lincoln, California
- +3 more
Apr 8, 2020